AmerisourceBergen Corp (ABC, Financial) files its latest 10-K with SEC for the fiscal year ended on September 30, 2018. AmerisourceBergen Corp is a pharmaceutical services company. It provides drug distribution and related healthcare services and solutions to pharmacy, physician, and manufacturer customers based in the United States and Canada. AmerisourceBergen Corp has a market cap of $19.23 billion; its shares were traded at around $88.87 with a P/E ratio of 11.80 and P/S ratio of 0.12. The dividend yield of AmerisourceBergen Corp stocks is 1.75%. AmerisourceBergen Corp had annual average EBITDA growth of 10.90% over the past ten years. GuruFocus rated AmerisourceBergen Corp the business predictability rank of 4-star.
For the last quarter AmerisourceBergen Corp reported a revenue of $43.3 billion, compared with the revenue of $39.1 billion during the same period a year ago. For the latest fiscal year the company reported a revenue of $167.9 billion, an increase of 9.7% from last year. For the last five years AmerisourceBergen Corp had an average revenue growth rate of 12.3% a year.
The reported diluted earnings per share was $7.53 for the year, an increase of 359.1% from previous year. The AmerisourceBergen Corp had an operating margin of 0.9%, compared with the operating margin of 1.29% a year before. The 10-year historical median operating margin of AmerisourceBergen Corp is 1.22%. The profitability rank of the company is 7 (out of 10).
At the end of the fiscal year, AmerisourceBergen Corp has the cash and cash equivalents of $2.5 billion, compared with $2.4 billion in the previous year. The long term debt was $4.2 billion, compared with $3.4 billion in the previous year. AmerisourceBergen Corp has a financial strength rank of 7 (out of 10).
At the current stock price of $88.87, AmerisourceBergen Corp is traded at 10.3% discount to its historical median P/S valuation band of $99.11. The P/S ratio of the stock is 0.12, while the historical median P/S ratio is 0.13. The intrinsic value of the stock is $80.58 a share, according to GuruFocus DCF Calculator. The stock gained 17.15% during the past 12 months.
CEO Recent Trades:
- Chairman, President & CEO Steven H Collis sold 21,350 shares of ABC stock on 11/01/2018 at the average price of $90.92. The price of the stock has decreased by 2.25% since.
Directors and Officers Recent Trades:
- Executive Vice President John G. Chou sold 6,974 shares of ABC stock on 11/15/2018 at the average price of $88.51. The price of the stock has increased by 0.41% since.
- Executive Vice President Kathy H. Gaddes sold 2,652 shares of ABC stock on 10/22/2018 at the average price of $92.96. The price of the stock has decreased by 4.4% since.
For the complete 20-year historical financial data of ABC, click here.
